135 related articles for article (PubMed ID: 1106849)
21. Phase II trial adriamycin and cis-dichlorodiammineplatinum(II) in squamous cell, ovarian, and testicular carcinomas.
Bonomi PD; Slayton RE; Wolter J
Cancer Treat Rep; 1978 Aug; 62(8):1211-3. PubMed ID: 356979
[No Abstract] [Full Text] [Related]
22. cis-Dichlorodiammineplatinum(II) and bleomycin in the treatment of esophageal carcinomas.
Kelsen DP; Cvitkovic E; Bains M; Shils M; Howard J; Hopfan S; Golbey RB
Cancer Treat Rep; 1978 Jul; 62(7):1041-6. PubMed ID: 80269
[TBL] [Abstract][Full Text] [Related]
23. Cis-dichlorodiammineplatinum(II) in metastatic soft tissue sarcomas.
Karakousis CP; Holtermann OA; Holyoke ED
Cancer Treat Rep; 1979; 63(11-12):2071-5. PubMed ID: 393389
[TBL] [Abstract][Full Text] [Related]
24. Cancer of the ovary: a summary of experience with cis-dichlorodiammineplatinum(II) at the Royal Marsden Hospital.
Wiltshaw E; Subramarian S; Alexopoulos C; Barker GH
Cancer Treat Rep; 1979; 63(9-10):1545-8. PubMed ID: 387225
[TBL] [Abstract][Full Text] [Related]
25. Clinical phase I-II study of cis-dichloro-diammineplatinum(II) given by continuous lv infusion.
Salem P; Hall SW; Benjamin RS; Murphy WK; Wharton JT; Bodey GP
Cancer Treat Rep; 1978 Oct; 62(10):1553-5. PubMed ID: 361227
[TBL] [Abstract][Full Text] [Related]
26. Combination chemotherapy with methotrexate (NSC-740), adriamycin (NSC-123127), cyclophosphamide (NSC-26271), and 5-fluorouracil (NSC19893) for adult solid tumors.
Stephens RL; Hoogstraten B
Cancer Chemother Rep; 1974; 58(6):943-5. PubMed ID: 4614901
[No Abstract] [Full Text] [Related]
27. Treatment of tumours with the combination of WR-2721 and cis-dichlorodiammineplatinum (II) or cyclophosphamide.
Yuhas JM; Spellman JM; Jordan SW; Pardini MC; Afzal SM; Culo F
Br J Cancer; 1980 Oct; 42(4):574-85. PubMed ID: 6254555
[TBL] [Abstract][Full Text] [Related]
28. Phase II study in advanced sarcoma: randomized trial of pyrazofurin versus combination cyclophosphamide, doxorubicin, and cis-dichlorodiammineplatinum(II) (CAP).
Cormier WJ; Hahn RG; Edmonson JH; Eagan RT
Cancer Treat Rep; 1980; 64(4-5):655-8. PubMed ID: 7191779
[TBL] [Abstract][Full Text] [Related]
29. Phase II study of cis-dichlorodiammineplatinum(II) in advanced breast cancer.
Yap HY; Salem P; Hortobagyi GN; Bodey GP; Buzdar AU; Tashima CK; Blumenschein GR
Cancer Treat Rep; 1978 Mar; 62(3):405-8. PubMed ID: 348308
[TBL] [Abstract][Full Text] [Related]
30. Clinical response and toxicity with cis-dichlorodiammineplatinum(II) in children.
Kamalakar P; Freeman AI; Higby DJ; Wallace HJ; Sinks LF
Cancer Treat Rep; 1977 Aug; 61(5):835-9. PubMed ID: 890692
[TBL] [Abstract][Full Text] [Related]
31. Clinical trial of combined therapy with adriamycin and cis-dichlorodiammineplatinum(II).
Mills RC; Maurer LH; Forcier RJ; Grace WR; Burke GP; Karp DD; Smith RC; Mcintyre OR; Bean C
Cancer Treat Rep; 1977; 61(3):477-9. PubMed ID: 872146
[No Abstract] [Full Text] [Related]
32. cis-Dichlorodiammineplatinum(II) in the treatment of gynecologic malignancies: phase II trials by the Gynecologic Oncology Group.
Thigpen T; Shingleton H; Homesley H; LaGasse L; Blessing J
Cancer Treat Rep; 1979; 63(9-10):1549-55. PubMed ID: 498154
[TBL] [Abstract][Full Text] [Related]
33. Advanced ovarian carcinoma: a pilot study of cis-dichlorodiammineplatinum(II) in combination with adriamycin and cyclophosphamide in previously untreated patients and as a single agent in previously treated patients.
Williams CJ; Stevenson KE; Buchanan RB; Whitehouse JM
Cancer Treat Rep; 1979; 63(11-12):1745-53. PubMed ID: 393378
[No Abstract] [Full Text] [Related]
34. cis-Dichlorodiammineplatinum(II) for the treatment of advanced ovarian cancer.
Young RC; Von Hoff DD; Gormley P; Makuch R; Cassidy J; Howser D; Bull JM
Cancer Treat Rep; 1979; 63(9-10):1539-44. PubMed ID: 387224
[TBL] [Abstract][Full Text] [Related]
35. Phase II trial cisplatin, doxorubicin, and cyclophosphamide (CAP) in the treatment of urothelial transitional cell carcinoma.
Campbell M; Baker LH; Opipari M; Al-Sarraf M
Cancer Treat Rep; 1981; 65(9-10):897-9. PubMed ID: 7196800
[TBL] [Abstract][Full Text] [Related]
36. Clinical studies of Platinum Coordination compounds in the treatment of various malignant diseases.
Hill JM; Loeb E; MacLellan A; Hill NO; Khan A; King JJ
Cancer Chemother Rep; 1975; 59(3):647-59. PubMed ID: 1203889
[TBL] [Abstract][Full Text] [Related]
37. Toxic effects of cis-dichlorodiammineplatinum(II) in man.
Von Hoff DD; Schilsky R; Reichert CM; Reddick RL; Rozencweig M; Young RC; Muggia FM
Cancer Treat Rep; 1979; 63(9-10):1527-31. PubMed ID: 387223
[TBL] [Abstract][Full Text] [Related]
38. Vinblastine, intermittent bleomycin, and single-dose cis-dichlorodiammineplatinum(II) in the management of stge III testicular cancer.
Bosl GJ; Kwong R; Lange PH; Fraley EE; Kennedy BJ
Cancer Treat Rep; 1980; 64(2-3):331-4. PubMed ID: 6157467
[TBL] [Abstract][Full Text] [Related]
39. Phase II trial of cis-dichlorodiammineplatinum (II) in advanced malignant lymphoma: a study of the cancer and acute leukemia group B.
Cavalli F; Jungi WF; Nissen NI; Pajak TF; Coleman M; Holland JF
Cancer; 1981 Nov; 48(9):1927-30. PubMed ID: 7197582
[TBL] [Abstract][Full Text] [Related]
40. Phase II study of cis-dichlorodiammineplatinum(II) (NSC-119875) in advanced adenocarcinoma of the ovary.
Wiltshaw E; Kroner T
Cancer Treat Rep; 1976 Jan; 60(1):55-60. PubMed ID: 1000519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
